Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
NanoEthics
Published in: NanoEthics 2/2018

19-05-2018 | Original Paper

Nanomaterials in Cosmetic Products: the Challenges with regard to Current Legal Frameworks and Consumer Exposure

Authors: Homero Pastrana, Alba Avila, Candace S. J. Tsai

Published in: NanoEthics | Issue 2/2018

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Nanotechnology-enabled cosmetic products (NCPs) have been accessible in the market for the last 30 years. More than 250 products have been commercialized in the global market potentially exposing two billion people. These products are present in all formulations including creams, powders, lotions, and sprays. These involve contact with all body especially skin and mucosae; other tissues like airways and gastrointestinal tract can be reached by accidental exposure. Due to the size, NCPs exhibit an increased surface area volume ratio and biodistribution that potentially augments their reactivity compared with bulk materials, which raises concerns for consumer’s safety. Consumers are attracted by the novel properties and functions of nano-enabled products but expose to technologies where no legal frameworks have been implemented to prevent potential side effects. Here, we review the current gaps between the commercialization process of NCPs and the regulatory frameworks to assess these products in USA, Europe, Japan, and Latin America prior and after commercialization. We identify the requirements for a proper assessment of the potential hazard of nanomaterials (NMs) in cosmetics considering the nanomaterial properties.
previous article Nanotechnology Governance: from Risk Regulation to Informal Platforms
next article The Power of Analogies for Imagining and Governing Emerging Technologies

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

inform now
Literature
1.
Allied Market Research (2016) Cosmetics market size, share, industry trends and analysis. Allied Market Research, Portland
2.
Allied Market Research (2017) HIV drug market is expected to reach $26,458 million by 2022, globally. Allied Market Research, Portland
3.
Allied Market Research (2016) Regenerative medicine market to reach $30,237 million, globally, by 2022. Allied Market Research, Portland
4.
5.
L’Oréal (2016) L’Oréal annual report 2016: cosmetics market. L'Oréal, Paris
6.
7.
Owh C, Chee PL, Loh XJ (2016) A global analysis of the personal care market. In: Polymers for personal care products and cosmetics. Royal Society of Chemistry, Cambridge, pp 1–17
8.
Mu L, Sprando RL (2010) Application of nanotechnology in cosmetics. Pharm Res 27(8):1746–1749CrossRef
9.
DeLouise LA (2012) Applications of nanotechnology in dermatology. J Invest Dermatol 132:964–975CrossRef
10.
Fakhravar Z, Ebrahimnejad P, Daraee H, Akbarzadeh A (2016) Nanoliposomes: synthesis methods and applications in cosmetics. J Cosmet Laser Ther 18(3):174–181CrossRef
11.
Palmberg C, Dernis H, Miguet C (2009) Nanotechnology: an overview based on indicators and statistics. OECD, Paris
12.
Vance ME, Kuiken T, Vejerano EP, McGinnis SP, Hochella MF Jr, Rejeski D, Hull MS (2015) Nanotechnology in the real world: redeveloping the nanomaterial consumer products inventory. Beilstein J Nanotechnol 6(1):1769–1780CrossRef
13.
Foss Hansen S, Heggelund LR, Revilla Besora P, Mackevica A, Boldrin A, Baun A (2016) Nanoproducts—what is actually available to European consumers? Environ Sci Nano 3(1):169–180CrossRef
14.
Raj S, Jose S, Sumod US, Sabitha M (2012) Nanotechnology in cosmetics: opportunities and challenges. J Pharm Bioallied Sci 4(3):186–193CrossRef
15.
Vinardell MP, Llanas H, Marics L, Mitjans M (2017) In vitro comparative skin irritation induced by nano and non-nano zinc oxide. Nanomaterials (Basel) 7(3):56CrossRef
16.
Aschberger K, Micheletti C, Sokull-Klüttgen B, Christensen FM (2011) Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health—lessons learned from four case studies. Environ Int 37(6):1143–1156CrossRef
17.
Nohynek GJ, Antignac E, Re T, Toutain H (2010) Safety assessment of personal care products/cosmetics and their ingredients. Toxicol Appl Pharmacol 243(2):239–259CrossRef
18.
Betton CI (2007) Global regulatory issues for the cosmetics industry. Volume 1. William Andrew, Norwich, NY
19.
Lodén M, Beitner H, Gonzalez H, Edström DW, Åkerström U, Austad J, Buraczewska-Norin I, Matsson M, Wulf HC (2011) Sunscreen use: controversies, challenges and regulatory aspects. Br J Dermatol 165(2):255–262CrossRef
20.
Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311(5761):622–627CrossRef
21.
Savolainen K, Backman U, Brouwer D, Fadeel B, Fernandes T (2013) Nanosafety in Europe 2015–2025: towards safe and sustainable nanomaterials and nanotechnology innovations. Finnish Institute of Occupational Health, Helsinki
22.
European Parliament (2009) Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. European Parliament, Brussels
23.
European Commission (2013) 2013/674/EU: Commission Implementing Decision of 25 November 2013 on Guidelines on Annex I to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on Cosmetic Products. European Union, Luxembourg
24.
International Cooperation on Cosmetic Regulation (ICCR) (2011) Outcome of the Meeting held June 28 to July 1st, 2011. ICCR, Paris
25.
Wang H, Zhao X, He C (2016) Innovative permeation and antifouling properties of PVDF ultrafiltration membrane with stepped hollow SiO2 microspheres in membrane matrix. Mater Lett 182:376–379CrossRef
26.
Make-up composition producing a change in colour on application, September 2016, US Grant US9433804B2
27.
Gupta R, Rai B (2017) Effect of size and surface charge of gold nanoparticles on their skin permeability: a molecular dynamics study. Sci Rep 7:45292CrossRef
28.
Nikolić S, Keck CM, Anselmi C, Müller RH (2011) Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters. Int J Pharm 414(1–2):276–284CrossRef
29.
Boverhof DR, Bramante CM, Butala JH, Clancy SF, Lafranconi M, West J, Gordon SC (2015) Comparative assessment of nanomaterial definitions and safety evaluation considerations. Regul Toxicol Pharmacol 73(1):137–150CrossRef
30.
Guadagnini R, Halamoda Kenzaoui B, Walker L, Pojana G, Magdolenova Z, Bilanicova D, Saunders M, Juillerat-Jeanneret L, Marcomini A, Huk A, Dusinska M, Fjellsbø LM, Marano F, Boland S (2015) Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests. Nanotoxicology 9(sup1):13–24CrossRef
31.
Bergfeld WF, Belsito DV, Marks JG, Andersen FA (2005) Safety of ingredients used in cosmetics. J Am Acad Dermatol 52(1):125–132CrossRef
32.
33.
34.
35.
NeimanMarcus (n.d.): Lancome Hydra Flash Bronzer Daily Face Moisturizer [not online anymore; last accessed 22 Sep 2017
36.
37.
38.
Bacterial medical nano suppository for woman and its preparing process, May 2005, CN Grant CN1202868C
39.
40.
41.
42.
43.
Sanchez VC, Jachak A, Hurt RH, Kane AB (2012) Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol 25(1):15–34CrossRef
44.
Zhao J, Castranova V (2011) Toxicology of nanomaterials used in nanomedicine. J Toxicol Environ Health B Crit Rev 14(8):593–632CrossRef
45.
Chen Y, Liu L (2012) Modern methods for delivery of drugs across the blood-brain barrier. Adv Drug Deliv Rev 64(7):640–665CrossRef
46.
Bergin IL, Witzmann FA (2013) Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol 3(1–2):163-210CrossRef
47.
Luanpitpong S, Wang L, Castranova V, Rojanasakul Y (2014) Induction of stem-like cells with malignant properties by chronic exposure of human lung epithelial cells to single-walled carbon nanotubes. Part Fibre Toxicol 11:22CrossRef
48.
Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D (2005) Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 207(3):221–231CrossRef
49.
Jacobsen NR, Møller P, Alstrup Jensen K, Vogel U, Ladefoged O, Loft S, Wallin H (2009) Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE−/− mice. Part Fibre Toxicol 6:2
50.
Kolosnjaj-Tabi J, Just J, Hartman KB, Laoudi Y, Boudjemaa S, Alloyeau D, Szwarc H, Wilson LJ, Moussa F (2015) Anthropogenic carbon nanotubes found in the airways of Parisian children. EBioMedicine 2(11):1697–1704CrossRef
51.
Waters KM, Masiello LM, Zangar RC, Tarasevich BJ, Karin NJ, Quesenberry RD, Bandyopadhyay S, Teeguarden JG, Pounds JG, Thrall BD (2009) Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol Sci 107(2):553–569CrossRef
52.
Song Y, Tang S (2011) Nanoexposure, unusual diseases, and new health and safety concerns. ScientificWorldJournal 11:1821–1828CrossRef
53.
Ma-hock L, Strauss V, Treumann S, Küttler K, Wohlleben W, Hofmann T (2013) Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol 10:23
54.
Wang L, Wang L, Ding W, Zhang F (2010) Acute toxicity of ferric oxide and zinc oxide nanoparticles in rats. J Nanosci Nanotechnol 10(12):8617–8624CrossRef
55.
Cao Y, Jacobsen NR, Danielsen PH, Lenz AG, Stoeger T, Loft S, Wallin H, Roursgaard M, Mikkelsen L, Møller P (2014) Vascular effects of multiwalled carbon nanotubes in dyslipidemic ApoE-/- mice and cultured endothelial cells. Toxicol Sci 138(1):104–116CrossRef
56.
Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, Young SH, Shvedova A, Luster MI, Simeonova PP (2007) Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect 115(3):377–382CrossRef
57.
Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW (2012) Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis. Int J Nanomedicine 7:631–639CrossRef
58.
Abdelhalim MAK (2011) The effects of size and period of administration of gold nanoparticles on rheological parameters of blood plasma of rats over a wide range of shear rates: in vivo. Lipids Health Dis 10:191CrossRef
59.
Faedmaleki F, Shirazi FH, Salarian AA, Ahmadi Ashtiani H, Rastegar H (2014) Toxicity effect of silver nanoparticles on mice liver primary cell culture and HepG2 cell line. Iran J Pharm Res 13(1):235–242
60.
Neerman MF, Zhang W, Parrish AR, Simanek EE (2004) In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery. Int J Pharm 281(1–2):129–132CrossRef
61.
Møller P, Christophersen DV, Jensen DM, Kermanizadeh A, Roursgaard M, Jacobsen NR, Hemmingsen JG, Danielsen PH, Cao Y, Jantzen K, Klingberg H, Hersoug LG, Loft S (2014) Role of oxidative stress in carbon nanotube-generated health effects. Arch Toxicol 88(11):1939–1964CrossRef
62.
Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, Wang T, Yuan H, Ye C, Zhao F, Chai Z, Zhu C, Fang X, Ma B, Wan L (2006) Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 163(2):109–120CrossRef
63.
Reddy ARN, Reddy YN, Krishna DR, Himabindu V (2010) Multi wall carbon nanotubes induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells. Toxicology 272(1–3):11–16CrossRef
64.
Zhao J, Li N, Wang S, Zhao X, Wang J, Yan J, Ruan J, Wang H, Hong F (2010) The mechanism of oxidative damage in the nephrotoxicity of mice caused by nano-anatase TiO2. J Exp Nanosci 5:447–462CrossRef
65.
Ivanov S, Zhuravsky S, Yukina G, Tomson V, Korolev D, Galagudza M (2012) In vivo toxicity of intravenously administered silica and silicon nanoparticles. Materials (Basel) 5(12):1873–1889CrossRef
66.
Lee S, Khang D, Kim S-H (2015) High dispersity of carbon nanotubes diminishes immunotoxicity in spleen. Int J Nanomedicine 10:2697–2710CrossRef
67.
Deng X, Wu F, Li Z, Luo M, Li L, Ni Q, Jiao Z, Wu M, Liu Y (2009) The splenic toxicity of water soluble multi-walled carbon nanotubes in mice. Carbon 47(6):1421–1428
68.
Máté Z, Horváth E, Kozma G, Simon T, Kónya Z, Paulik E, Papp A, Szabó A (2016) Size-dependent toxicity differences of intratracheally instilled manganese oxide nanoparticles: conclusions of a subacute animal experiment. Biol Trace Elem Res 171(1):156–166CrossRef
69.
Feng X, Chen A, Zhang Y, Wang J, Shao L, Wei L (2015) Central nervous system toxicity of metallic nanoparticles. Int J Nanomedicine 10(1):4321–4340
70.
Hu R, Zheng L, Zhang T, Gao G, Cui Y, Cheng Z, Cheng J, Hong M, Tang M, Hong F (2011) Molecular mechanism of hippocampal apoptosis of mice following exposure to titanium dioxide nanoparticles. J Hazard Mater 191(1–3):32–40CrossRef
71.
Ema M, Hougaard KS, Kishimoto A, Honda K (2016) Reproductive and developmental toxicity of carbon-based nanomaterials: a literature review. Nanotoxicology 10(4):391–412CrossRef
72.
Domeradzka-Gajda K, Nocuń M, Roszak J, Janasik B, Quarles Jr. CD, Wąsowicz W, Grobelny J, Tomaszewska E, Celichowski G, Ranoszek-Soliwoda K, Cieślak M, Puchowicz D, Gonzalez JJ, Russo RE, Stępnik M (2017) A study on the in vitro percutaneous absorption of silver nanoparticles in combination with aluminum chloride, methyl paraben or di-n-butyl phthalate. Toxicol Lett 272:38–48CrossRef
73.
Zhang L, Yu W, Colvin V, Monteiroriviere N (2008) Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol 228(2):200–211CrossRef
74.
Pierzchała K, Lekka M, Magrez A, Kulik AJ, Forró L, Sienkiewicz A (2012) Photocatalytic and phototoxic properties of TiO2-based nanofilaments: ESR and AFM assays. Nanotoxicology 6:813–824CrossRef
75.
Santamaria A. and Sayes C. M. (2010) Toxicological studies with nanoscale materials. In: Hull M, Bowman D (ed) Nanotechnology Environmental Health and Safety. 1st edn. William Andrew. pp 3-47
76.
Pauwels M, Rogiers V (2004) Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist. Toxicol Lett 151(1):7–17CrossRef
77.
Bowman IE (2010) Consumer Product Safety Commission: CPSIA implementation. In Bowman IE (ed) Consumer Product Safety Commission issues. Nova Science Publishers, Hauppauge, pp 69-83
78.
Díez-Sales O., Nacher A., Merino M., Merino V. (2018) Alternative Methods to Animal Testing in Safety Evaluation of Cosmetic Products. In: Salvador A., Chisvert A (ed). Analysis of Cosmetic Products, 2nd edn. Elsevier, Valencia, pp 551-584
79.
Rhomberg RH, Goodman JE, Lewandowski TA (2010) Comprehensive toxicology. Elsevier, Kidlington
80.
Lynch I, Weiss C, Valsami-Jones E (2014) A strategy for grouping of nanomaterials based on key physico-chemical descriptors as a basis for safer-by-design NMs. Nano Today 9(3):266–270CrossRef
81.
Riebeling C, Luch A, Götz ME (2016) Comparative modeling of exposure to airborne nanoparticles released by consumer spray products. Nanotoxicology 10(3):343–351CrossRef
82.
Karlsson HL, Gustafsson J, Cronholm P, Möller L (2009) Size-dependent toxicity of metal oxide particles—a comparison between nano- and micrometer size. Toxicol Lett 188(2):112–118CrossRef
83.
US Food and Drug Administration (FDA) (2017) Nutrition, laboratory methods—BAM: microbiological methods for cosmetics. FDA, Silver Spring
84.
Lin P-C, Lin S, Wang PC, Sridhar R (2014) Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv 32(4):711–726CrossRef
85.
Pauwels M, Rogiers V (2010) Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science. Toxicol Appl Pharmacol 243(2):260–274CrossRef
86.
Guinée JB, Heijungs R, Huppes G, Zamagni A, Masoni P, Buonamici R,  Ekvall T, Rydberg T (2011) Life cycle assessment: past, present, and future. Environ Sci Technol 45(1):90–96
87.
Kapoor S, Saraf S (2008) Risk analysis tools for toxicological profile of cosmetics Internet J Toxicol 5:2
88.
Fiorino DJ (2010) Voluntary initiatives, regulation, and nanotechnology oversight: charting a path. WWICS, Washington DC
89.
90.
US Food and Drug Administration (FDA) (2012) Guidance documents—guidance for industry: safety of nanomaterials in cosmetic products. FDA, Silver Spring
91.
Basketter D, White I (2016) Legislative aspects of cosmetic safety in the European Union: the case of contact allergy. Cosmetics 3(2):17CrossRef
92.
Scientific Committee on Consumer Safety (SCCS) (2015) Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation, 9th revision, 29 September 2015, SCCS/1564/15, revision of 25 April 2016. European Union, Brussels
93.
ISO (2012) ISO/TR 13014:2012 Nanotechnologies—guidance on physico-chemical characterization of engineered nanoscale materials for toxicologic assessment. ISO/TC 229 Nanotechnologies
94.
Scientific Committee on Consumer Safety (SCCS) (2013) Commission implementation decision of 25 November 2013 on guidelines on Annex I to Regulation (EC) no 1223/2009 of the European Parliament and of the council on cosmetic products. European Union, Brussels
95.
96.
EU-Japan Centre for Industrial Cooperation (2009) Seminar Report 2009-6. Industrial Policy Seminar Series “Cosmetics regulation in the EU and Japan”. EU-Japan Centre for Industrial Cooperation
97.
98.
Mercosur (1991) MERCOSUR/CMC/DEC. N°04/91. Consejo del Mercado Común del Sur, Brasilia
99.
Comunidad Andina de Naciones (2003) Comunidad Andina—Decisión 563. Comisión de la Comunidad Andina
100.
Consejo del Mercado Común del Sur (2011) Mercosur/GMC/Resolución No 24/11. Consejo del Mercado Común del Sur, Asuncion
101.
Mercosur (2008) Mercosur/Resolución No 49/08. Consejo del Mercado Común del Sur
102.
JETRO (2011) Guidebook for export to Japan 2011 (cosmetics). JETRO
103.
Hampton T (2006) Nanotechnology task force. JAMA 296(12):1458–1458
104.
European Commission (2004) Towards a European strategy for nanotechnology. European Union, Luxembourg
105.
Musazzi UM, Marini V, Casiraghi A, Minghetti P (2017) Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials? Drug Discov Today 22(6):870–882CrossRef
106.
International Cooperation on Cosmetic Regulation (ICCR) (2010) Nanotechnology in cosmetic products: criteria and methods of detection. ICCR, Toronto
107.
Metadata
Title
Nanomaterials in Cosmetic Products: the Challenges with regard to Current Legal Frameworks and Consumer Exposure
Authors
Homero Pastrana
Alba Avila
Candace S. J. Tsai
Publication date
19-05-2018
Publisher
Springer Netherlands
Published in
NanoEthics / Issue 2/2018
Print ISSN: 1871-4757
Electronic ISSN: 1871-4765
DOI
https://doi.org/10.1007/s11569-018-0317-x

Other articles of this Issue 2/2018

NanoEthics 2/2018 Go to the issue

Original Paper

Nanotechnology Governance: from Risk Regulation to Informal Platforms

Editorial

Science, Technology and the Public

Original Paper

Assembling Upstream Engagement: the Case of the Portuguese Deliberative Forum on Nanotechnologies

Original Paper

Frame Reflection Lab: a Playful Method for Frame Reflection on Synthetic Biology

Response

Response to Article 309

Original Paper

Models of Public Engagement: Nanoscientists’ Understandings of Science–Society Interactions